Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Aydin S. Z., Robson J. C., Sreih A. G., Hill C., Alibaz-Oner F., Mackie S., ...Daha Fazla

JOURNAL OF RHEUMATOLOGY, cilt.46, sa.9, ss.1198-1201, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 9
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3899/jrheum.181072
  • Dergi Adı: JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1198-1201
  • Anahtar Kelimeler: VASCULITIS, TAKAYASU ARTERITIS, GIANT CELL ARTERITIS, LARGE-VESSEL VASCULITIS, OUTCOMES, OMERACT, QUALITY-OF-LIFE, GIANT-CELL ARTERITIS, DISEASE-ACTIVITY, TAKAYASUS-ARTERITIS, ACTIVITY SCORE, HEALTH
  • Marmara Üniversitesi Adresli: Evet

Özet

Objective. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group seeks to develop validated outcome measures for use in trials for large-vessel vasculitis (LVV).